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Global increases in small ubiquitin-like modifier (SUMO)-
2/3 conjugation are a neuroprotective response to severe
stress but the mechanisms and specific target proteins that
determine cell survival have not been identified. Here, we
demonstrate that the SUMO-2/3-specific protease SENP3
is degraded during oxygen/glucose deprivation (OGD), an
in vitro model of ischaemia, via a pathway involving the
unfolded protein response (UPR) kinase PERK and
the lysosomal enzyme cathepsin B. A key target for
SENP3-mediated deSUMOylation is the GTPase Drp1,
which plays a major role in regulating mitochondrial
fission. We show that depletion of SENP3 prolongs Drp1
SUMOylation, which suppresses Drp1-mediated cyto-
chrome c release and caspase-mediated cell death. SENP3
levels recover following reoxygenation after OGD allowing
deSUMOylation of Drp1, which facilitates Drp1 localiza-
tion at mitochondria and promotes fragmentation and
cytochrome c release. RNAi knockdown of SENP3 protects
cells from reoxygenation-induced cell death via a mechan-
ism that requires Drp1 SUMOylation. Thus, we identify a
novel adaptive pathway to extreme cell stress in which
dynamic changes in SENP3 stability and regulation of
Drp1 SUMOylation are crucial determinants of cell fate.
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Introduction
Post-translational modification of substrate proteins by the
covalent attachment of small ubiquitin-like modifier (SUMO)
proteins regulates multiple cellular pathways, ranging from
nuclear organization and transcriptional regulation to mem-
brane protein trafficking and stability (Wilkinson and Henley,
2010). There are three SUMO paralogues (SUMO-1–3) in
mammals, which are conjugated to lysine residues in target
proteins by an enzymatic pathway comprising an E1 complex,
SAE1/SAE2, a single E2, Ubc9 and various E3 enzymes
(Wilkinson and Henley, 2010). SUMO-2 and SUMO-3 differ by
just three N-terminal amino acids, but share only B50%
sequence identity to SUMO-1. SUMO proteins are
deconjugated from substrates via the actions of the SENP
family of SUMO-specific isopeptidases. There are six
mammalian SENPs: SENP1–3 and SENP5–7. Of these, SENP1
and 2 show a broad specificity against SUMO-1 and SUMO-2/3,
SENP3 and SENP5 favour removal of SUMO-2/3 over SUMO-1
and SENP6–7 edit SUMO-2/3 chains on substrates (Yeh, 2009).
Thus, the dynamic balance between Ubc9-mediated SUMO
conjugation and SENP-mediated SUMO removal determines
the SUMOylation status of substrate proteins.
Brain ischaemia is a major cause of death and disability. It
occurs when the blood supply to a part of the brain is
interrupted by trauma, occlusion following a stroke or by
heart failure. The oxygen and glucose deprivation (OGD)
during ischaemia, and the reperfusion damage that occurs
when the blood supply is restored and oxygen and glucose
become available, exposes cells to extreme metabolic stress.
At the cellular level, ischaemia causes ATP depletion,
glutamate excitotoxicity, calcium overload, mitochondrial
dysfunction and oxidative damage. To counteract these stres-
sors, cells utilize a variety of adaptive responses to decrease
energy expenditure, increase nutrient availability and pro-
mote cell survival. The endoplasmic reticulum unfolded
protein response (UPR) is activated when misfolded proteins
accumulate in the ER lumen as a result of oxidative stress
(Hetz, 2012). The protein kinase RNA (PKR)-like ER kinase
(PERK) is a critical initiator of UPR signalling, which attempts
to restore normal ER function by inhibiting general protein
synthesis while promoting transcription of ER chaperones
and folding enzymes to enhance ER processing and
alleviate protein aggregation (Yang and Paschen, 2009). The
UPR initially promotes cell survival; however, when
overwhelmed, it initiates pro-apoptotic pathways involving
signalling to B-cell lymphoma protein 2 (Bcl-2) family
proteins located at mitochondria (Szegezdi et al, 2009).
Thus, the UPR is fundamental in dictating whether cells
survive post-ischaemia through signalling to mitochondria.
SUMOylation is strongly implicated in a range of neurode-
generative disorders, suggesting a critical role for protein
SUMOylation in regulating neuronal function (Wilkinson
et al, 2010) and dysfunction (Dorval and Fraser, 2007;
Anderson et al, 2009). In response to ischaemic stress,
global levels of SUMO-2/3 conjugation are massively
enhanced in neurons (Cimarosti et al, 2008, 2012; Yang
et al, 2008a, b). Intriguingly, protein SUMO-2/3-ylation is
also increased in the brains of hibernating animals leading to
the proposal that it constitutes a cytoprotective pathway for
ischaemic preconditioning (Lee et al, 2007). This is supported
by observations that overexpression of SUMO-1 or SUMO-2
can increase resistance to ischaemia (Lee et al, 2009), and
silencing SUMO-2/3 using microRNA makes cells more
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vulnerable to ischaemic stress (Datwyler et al, 2011).
However, the mechanisms that regulate protein SUMO-
ylation and the identity of many of the substrate proteins
involved in the adaptive response to stress have remained
elusive.
Severe ischaemia causes cell death through cytochrome c
release into the cytosol, which leads to caspase cleavage and
apoptosis. Cytochrome c can be released by mitochondrial
fission (Wilson et al, 2013) and/or via mitochondrial outer
membrane permeabilization (MOMP) through the formation
of channels by oligomerization of the pro-apoptotic Bcl-2
family members on the outer mitochondrial membrane
(Montessuit et al, 2010). The mitochondrial GTPase
dynamin-related protein 1 (Drp1) plays key roles in
both fission and MOMP. Under basal conditions, Drp1 is
primarily localized in the cytosol but when recruited
to the mitochondrial membrane it can assemble into spiral
structures that wrap around the mitochondria to mediate
fission (Frank et al, 2001; Cassidy-Stone et al, 2008;
Jourdain and Martinou, 2009; Wilson et al, 2013).
Additionally, in response to apoptotic stimuli Drp1 is
recruited to the mitochondrial membrane to initiate
oligomerization of the pro-apoptotic Bcl-2 family proteins
Bax and Bak and activate MOMP (Montessuit et al, 2010).
Inhibition of Drp1 is neuroprotective against glutamate
excitotoxicity and OGD in cultured cells, and ischaemic
brain damage in vivo (Grohm et al, 2012). Furthermore,
depending on the conditions, either upregulation or
downregulation of Drp1 has been reported to protect
against apoptosis (Lee et al, 2004; Szabadkai et al, 2004).
Drp1 has been reported to be a substrate for both SUMO-1
and SUMO-2/3 conjugation, and it has been suggested that
SUMOylation may regulate the partitioning of Drp1 between
mitochondria and the cytosol (Wasiak et al, 2007; Figueroa-
Romero et al, 2009).
We investigated the molecular mechanisms of
SUMOylation in the cellular response to OGD. We show
that levels of the SUMO-2/3-specific deSUMOylating enzyme
SENP3 are greatly reduced during OGD via a pathway that
requires activation of the UPR-associated kinase PERK. This
downregulation of SENP3 increases Drp1 SUMO-2/3-ylation
and decreases its mitochondrial association, which
reduces Drp1-dependent cytochrome c release via reduced
mitochondrial fission and fragmentation. Thus, the loss of
SENP3 during ischaemia enhances cell survival. However,
SENP3 levels recover during reoxygenation after OGD leading
to Drp1 dSUMOylation, which is instrumental in initiating
apoptotic cell death. Taken together, our results reveal a novel
pro-survival cross-talk pathway between the UPR and mito-
chondria, mediated through loss of the deSUMOylating
enzyme SENP3. Furthermore, our results demonstrate
that SUMO-2/3-ylation of Drp1 is a crucial determinant of
cell survival after ischaemic insult.
Results
OGD enhances SUMO-2/3 conjugation by degrading
SENP3
OGD in dissociated primary cultured rat cortical neurons
caused a substantial increase in SUMO-2/3 conjugation
(Figure 1A) but not in SUMO-1 conjugation (Supplementary
Figure 1A). Levels of sumo-3 and sumo-2 mRNA were
unchanged and significantly reduced respectively, indicating
that increased SUMO-2/3-ylation was not due to increased
transcription (Figure 1B). We therefore investigated the
effects of OGD on the deSUMOylating SENP enzymes in
Figure 1 OGD increases global SUMO-2/3 conjugation and decreases SENP3 in neurons. (A) Lysates of primary cortical neurons were blotted
for SUMO-2/3 and b-tubulin after OGD (1 h). (B) sumo-2 mRNA levels are decreased and sumo-3 mRNA levels remain unchanged after OGD
(1 h) in primary cortical neurons. (C) Levels of SENP3 are reduced in neurons after OGD (30 min). (D) OGD (30 min) does not alter SENP1,
SENP2 or SENP5 levels in neurons. (E) senp3 mRNA levels are not reduced by OGD (1 h). For (B) and (E) significance was determined using a
two-tailed Paired t-test; for sumo-2 mRNA (n¼ 9; **Po0.01), for sumo-3 mRNA (n¼ 7) and for senp3 mRNA (n¼ 8). Source data for this figure
is available on the online supplementary information page.
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cultured neurons. Levels of the SUMO-2/3-specific protease
SENP3 were dramatically reduced immediately following
OGD (Figure 1C), whereas levels of SENP1, 2 and 5 remained
relatively unchanged (Figure 1D). Levels of senp3
mRNA were not significantly altered by OGD (Figure 1E).
We also observed a substantial increase in SUMO-2/3
conjugation in HEK293 cells and a corresponding marked
decrease in SENP3 levels immediately after OGD (Supple-
mentary Figure 1B). After termination of OGD followed by
reoxygenation, levels of endogenous SENP3 recovered with a
time course that mirrored the decrease in global SUMO-2/3
conjugation (Supplementary Figure 1C). Indeed, consistent
with the inverse correlation between SENP3 levels and
SUMO-2/3-ylation, SENP3 knockdown significantly increased
SUMO-2/3 conjugation in all cell types investigated
(Supplementary Figure 1D). Furthermore, SENP3 knockdown
occluded the OGD-induced increase in SUMO-2/3 conjuga-
tion in HEK293 cells (Supplementary Figure 1E). Taken
together, these findings suggest that levels of SENP3
are tightly controlled during and after OGD to regulate
SUMO-2/3 conjugation.
PERK activation is required for SENP3 degradation
The ER kinase PERK is activated by ischaemia and
reperfusion (Kumar et al, 2001). We detected increased
levels of phosphorylated, active PERK (p-PERK) in cultured
neurons following OGD (Figure 2A). To explore if PERK
activation is required for SENP3 degradation during OGD,
we co-expressed HA-PERK and Flag-SENP3 in HEK293 cells.
PERK expression dramatically decreased SENP3 levels
Figure 2 PERK activation is required for decreased SENP3. (A) PERK is phosphorylated (p-PERK) in neurons by OGD (30 min). Blots were
probed with phospho-PERK, PERK and b-tubulin antibodies. (B) Overexpression of HA-PERK causes loss of Flag-SENP3 in HEK293 cells, which
is blocked by overexpression of the PERK inhibitor p58IPK. Lysates were blotted with Flag, phospho-PERK and HA antibodies. (C) The kinase
activity of PERK is required for SENP3 removal in HEK293 cells. HA-PERK, but not kinase-dead HA-PERK K618A decreases SENP3. The top
panel shows the effect of PERK on overexpressed Flag-SENP3, while the lower panel shows endogenous SENP3. (D) PERK is required for
OGD-induced loss of SENP3. Confluent wild-type and PERK / MEFs were subjected to OGD (2 h), harvested and the lysates probed as
indicated. (E) Overexpression of HA-PERK in HEK293 cells reduces levels of SENP3 but not of SENP1, SENP2 or SENP5. Source data for this
figure is available on the online supplementary information page.
Figure 3 SENP3 regulates cytochrome c release via deSUMOylation of Drp1. (A) Overexpression of Flag-SENP3, but not inactive C532A mutant
causes cytochrome c release in HEK293 cells. The cytosol fraction or whole cell lysate was blotted for cytochrome c, Flag, and the cytosolic marker
GAPDH, or b-actin. (B) Overexpressing SENP3 decreases mitochondrial cytochrome c in HeLa cells. Fixed cells were immunostained to assess the
localization of cytochrome c in mitochondria labelled with MitoTracker. Representative images showing GFP-SENP3 (top panel) and GFP-SENP3
C532A expressing cells (lower panel, Green: SENP3; Red: MitoTracker; Blue: cytochrome c; scale bar: 10mm). White arrows indicate transfected
cells with percentages denoting the relative proportions of transfected cells with significantly reduced cytochrome c in mitochondria for wild-type
versus inactive mutant overexpression (n¼ 75 cells for GFP-SENP and n¼ 113 for GFP-SENP3 C532A). (C) SENP3-mediated cytochrome c release is
Drp1 dependent. HEK293 cells expressing Flag-SENP3 were treated with Mdivi-1 (50mM) for 4 h. The cytosol fraction or whole cell lysate was
blotted for cytochrome c, Smac/Diablo, Flag, and GAPDH, or b-actin. (D) Drp1 is SUMO-2-ylated in HEK293 cells expressing Flag-Ubc9, His-SUMO-
2 and HA-Drp1. Lysate was incubated with Ni2þ beads to precipitate His-SUMO-2-ylated proteins (His PD). (E) Overexpression of SENP3 decreases
Drp1 SUMOylation. Constructs expressing HA-Drp1, Flag-Ubc9, His-SUMO-2 and either GFP or GFP-SENP3 were transfected into HEK293 cells. (F)
SENP3 knockdown enhances Drp1 SUMOylation. Either non-specific siRNA (Nsi) or SENP3 siRNA (SENP3i) together with constructs expressing
HA-Drp1, Flag-Ubc9 and His-SUMO-2 were co-expressed in HEK293 cells. (G) OGD enhances Drp1 SUMOylation. Two days post transfection,
HEK293 cells were exposed to OGD (2 h). In (C–F), His-pulldown and lysate samples were blotted as indicated with antibodies against HA, Flag,
His, GFP, SENP3 and b-actin. (H) OGD (2 h) for primary cortical neurons increases SUMOylation of endogenous Drp1. (I) Preventing Drp1
SUMOylation results in cytochrome c release. YFP-Drp1R WTor Drp1R 4KR were expressed in HEK293 cells after knockdown of endogenous Drp1.
Source data for this figure is available on the online supplementary information page.
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via a mechanism dependent on its kinase activity since
co-expression of the PERK-specific inhibitor p58IPK
(Yan et al, 2002; Figure 2B) or expression of a kinase-dead
PERK mutant (K618A; Harding et al, 1999; Figure 2C) did not
reduce SENP3 levels. To further confirm a role for PERK in
regulating SENP3 stability, we subjected wild-type (WT) and
PERK / mouse embryonic fibroblasts (MEFs) (Harding
et al, 2001) to severe OGD. In MEFs from WT mice OGD
induced PERK phosphorylation and dramatically reduced
SENP3 levels. In stark contrast, OGD had no affect on
SENP3 in PERK / MEFs, indicating that PERK activation
is directly responsible for regulating SENP3 levels during
ischaemic stress (Figure 2D).
Although proteolysis of SENP3 requires PERK kinase
activity we were unable to detect direct PERK phosphoryla-
tion of SENP3 in in vitro [32P]ATP kinase assays or pulldown
experiments from HEK293 cells (Supplementary Figure 2A
and B). We individually mutated 11 serine and 3 threonine
Pro-apoptotic actions of SENP3 on Drp1
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residues in SENP3 identified as potential phosphorylation
sites to alanine and tested the resistance of the SENP3
mutants to PERK-mediated degradation. All of these mutants
were degraded when co-expressed with PERK (Supplemen-
tary Figure 2C).
An important PERK target is the eukaryotic initiation factor
eIF2a (Van Der Kelen et al, 2009), which under stress
conditions is phosphorylated by PERK to inhibit protein
synthesis (Koumenis et al, 2002). We used MEF cells
expressing a non-activatable form of eIF2a (eIF2a S51A)
(Scheuner et al, 2001) to test if PERK phosphorylation of
eIF2a plays a role in SENP3 degradation. OGD reduced
SENP3 levels in both WT and eIF2a S51A MEF cells,
indicating that phosphorylation of eIF2a and inhibition
of translation are not involved in the OGD-induced loss of
SENP3 (Supplementary Figure 2D).
SENP3 degradation does not involve ubiquitination but
requires cathepsin B
We next tested whether SENP3 degradation was dependent
on ubiquitination. Co-expression of SENP3 with ubiquitin
(Ub) or the chain-forming deficient mutant Ub K7R
indicated that SENP3 was efficiently mono-ubiquitinated
(Supplementary Figure 3A). However, mutation of K231, the
major ubiquitination site, did not prevent PERK-mediated
SENP3 degradation (Supplementary Figure 3B and C).
Furthermore, we individually mutated each of the 28 lysines
in SENP3 to arginine but observed no affect on PERK-
mediated degradation (Supplementary Figure 3D). Similarly,
a series of truncation mutants spanning the full length of
SENP3 (amino acids 1–200, 1–400 and 370–574) were each
susceptible to PERK-mediated degradation (Supplementary
Figure 3E). Taken together, these results suggest that canoni-
cal ubiquitin-mediated degradation is not responsible for
SENP3 loss during OGD.
Despite this apparent independence of ubiquitination,
OGD-induced SENP3 degradation was largely blocked by
co-application of the lysosome inhibitors leupeptin and chlor-
oquine, but was unaffected by application of the proteasome
inhibitor MG132, suggesting that SENP3 is susceptible to the
actions of lysosomal proteases (Supplementary Figure 3F).
Lysosomal rupture and release of cathepsin proteases can
trigger caspase-dependent cell death (Boya et al, 2003; Boya
and Kroemer, 2008) and cathepsin B is implicated in the UPR
stress response (Friedlander et al, 2000; Kim et al, 2006).
Since PERK-mediated SENP3 degradation can be blocked by
lysosomal inhibition, we investigated the effects of OGD on
cathepsin B in cortical neurons. The precursor protein pro-
cathepsin B was cleaved to active cathepsin B by OGD in
neurons (Supplementary Figure 4A) and PERK overexpres-
sion in HEK293 cells (Supplementary Figure 4B and C).
Importantly, selective inhibition of cathepsin B prevented
SENP3 degradation invoked by overexpression of PERK
(Supplementary Figure 4D) or OGD in HEK293 cells
(Supplementary Figure 4E). Additionally, cathepsin
B-mediated degradation of SENP3 was assessed in in vitro
assays. While GST was only slightly affected by incubation
with purified cathepsin B, GST-SENP3 was extensively de-
graded (Supplementary Figure 4F) suggesting that cathepsin
B directly degrades SENP3. We next measured PERK activa-
tion and SENP3 levels in cathepsin B / MEF cells subjected
to OGD. Consistent with the inhibitor data, in cathepsin
B / MEF cells, OGD still led to PERK activation, but
there was no decrease in SENP3 levels (Supplementary
Figure 4G). Thus, PERK-mediated maturation and release of
cathepsin B contribute to SENP3 proteolysis during OGD.
However, since cathepsin B inhibitor II did not entirely
prevent OGD-induced SENP3 loss in primary neuronal cul-
tures, we conclude that there are also other pathways present
in neurons that can degrade SENP3 during OGD.
SUMOylation of Drp1 regulates cytochrome c release
Pro-apoptotic stimuli cause cytochrome c release from mito-
chondria (Tait and Green, 2011) and, once in the cytosol,
cytochrome c initiates a caspase pathway that culminates in
cell death (Riedl and Salvesen, 2007). We therefore
investigated if SENP3 regulates cytochrome c release in
HEK293 cells. Overexpression of SENP3, but not the
inactive mutant SENP3 C532A, caused a marked increase
in cytosolic cytochrome c under basal conditions (Figure 3A).
In confocal imaging experiments, overexpression of SENP3
but not of SENP3 C532A consistently reduced the localization
of cytochrome c in mitochondria in HeLa cells (Figure 3B).
Although the majority of SENP3 is found in the nucleus,
there is robust cytosolic SENP3 immunostaining
(Supplementary Figure 5A). This raises the possibility that
extranuclear SENP3 regulates cytochrome c release through
deSUMOylation of cytosolic or mitochondrial SUMO
substrate(s). The mitochondrial GTPase Drp1 can regulate
cytochrome c release through mitochondrial fission (Wilson
et al, 2013) and/or via stimulation of Bax/Bak
oligomerization and MOMP (Montessuit et al, 2010). Drp1
is a SUMO substrate (Harder et al, 2004) so we tested if
SENP3-mediated cytochrome c release is dependent on Drp1
activity. Consistent with this, the selective Drp1 inhibitor
mitochondrial division inhibitor-1 (mdivi-1) (Cassidy-Stone
et al, 2008) markedly reduced SENP3-mediated cytochrome c
release in HEK293 cells (Figure 3C). Interestingly, however, in
contrast to cytochrome c, overexpression of SENP3 did not
increase the cytosolic localization of another intramembrane
space (IMS) protein Smac/Diablo (Figure 3C), suggesting that
Drp1 release is independent of MOMP.
Drp1 is efficiently conjugated by SUMO-2 in HEK293 cells
(Figure 3D; Supplementary Figure 5B) and this Drp1 SUMO-
2-ylation is abolished by SENP3 overexpression (Figure 3E).
Furthermore, Drp1 SUMOylation is promoted by SENP3
knockdown (Figure 3F) and, consistent with the OGD-
mediated loss of SENP3, OGD enhances Drp1 SUMO-2/
3-ylation in both HEK293 cells and neurons (Figure 3G and H).
To fully confirm the critical role for Drp1 SUMO-2/3-ylation
in cytochrome c release, we made a non-SUMOylatable Drp1
by mutating four acceptor lysines to arginines (Drp1 4KR;
Supplementary Figure 5C; Figueroa-Romero et al, 2009) and
used this in knockdown rescue experiments. Following
siRNA knockdown of endogenous Drp1, we expressed
RNAi-resistant YFP-Drp1R WT or a non-SUMOylatable
mutant Drp1R 4KR. As shown in Figure 3I, rescue with
YFP-Drp1R 4KR, but not Drp1R WT, caused a substantial
increase in cytochrome c levels in the cytosol with a corre-
sponding decrease in the mitochondrial fraction. Thus,
SUMOylation of Drp1 reduces its ability to evoke cytochrome
c release. This is consistent with our observations that SENP3
overexpression decreases Drp1 SUMOylation and enhances
the release of cytochrome c.
Pro-apoptotic actions of SENP3 on Drp1
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Figure 4 SENP3 regulates mitochondrial association of Drp1. (A) Knockdown of Drp1 decreases cytosolic cytochrome c. (B) Knockdown of
SENP3 decreases the mitochondrial association of endogenous Drp1 and reduces levels of cytosolic cytochrome c in HEK293 cells (n¼ 3;
**Po0.01). (C) SENP3 knockdown decreases mitochondrial localization of Drp1 in HeLa cells. Fixed cells were immunostained to assess the
co-localization of endogenous Drp1 with mitochondria. Representative images showing control (top panel, Nsi) and SENP3 knockdown cells
(lower panel, SENP3i; Green: Drp1; Red: MitoTracker; Yellow: co-localization of Drp1 and MitoTracker; Magenta: SENP3; Blue: Hoechst; scale
bar: 10mm). The region of interest defined by the white box is enlarged in the middle panels (scale bar: 5mm). Right hand panels illustrate the
individual channel data. The histogram shows the comparative levels of Drp1 localization at mitochondria (n¼ 36 cells for Nsi and n¼ 27 cells
for SENP3i; **Po0.01). (D) SENP3 overexpression increases localization of Drp1 at mitochondria in HEK293 cells (n¼ 3; *Po0.05). (E)
SUMOylation affects Drp1 dynamics. YFP-Drp1R WT or non-SUMOylatable Drp1R 4KR was expressed in HeLa cells after knockdown of
endogenous Drp1 and the cells subjected to FRAP analysis. The left hand images show the representative cells sampled and the subsequent
image panels are enlargements of frames at the specified time points (Green: YFP-DRP1R; Red: MitoTracker; Yellow: co-localization. Scale bar:
10 mm for first frame, 5mm for enlarged frames). The area defined by the white box is the photobleached region of interest. Recovery curves for
Drp1R WT (black) and Drp1R 4KR (white) are shown and the values presented in the table. Values¼mean±s.e.m. (n¼ 12 cells per condition).
(F) Non-SUMOylatable Drp1 shows enhanced mitochondrial association. YFP-Drp1R WT or Drp1R 4KR was expressed in HeLa cells after
knockdown of endogenous Drp1, and cytosolic fraction, mitochondrial fraction, or whole cell lysates were blotted as indicated. Source data for
this figure is available on the online supplementary information page.
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SUMOylation regulates mitochondrial association
of Drp1
We next explored how SENP3-mediated deSUMOylation
regulates Drp1 function and localization. As expected,
knockdown of Drp1 decreased basal levels of cytochrome c
release in HEK293 cells (Figure 4A). Similarly, under basal
conditions SENP3 knockdown decreased the amount of Drp1
localized at mitochondria and reduced cytochrome c release
(Figure 4B). Localization of endogenous Drp1 following
SENP3 knockdown was determined in HeLa cells by immu-
nocytochemistry. Consistent with SENP3 removal decreasing
Drp1 association with the mitochondria, we observed re-
duced co-localization of Drp1 with MitoTracker following
SENP3 knockdown (Figure 4C). Conversely, SENP3 over-
expression promoted mitochondrial localization of Drp1
and increased cytochrome c release (Figure 4D). Taken
together, these data indicate that enhanced Drp1
SUMOylation, facilitated by reduced levels of SENP3, reduces
mitochondrial localization and downregulates cytochrome c
release.
We next used knockdown of endogenous Drp1 and inves-
tigated the mitochondrial association of RNAi-resistant YFP-
Drp1R WT and non-SUMOylatable YFP-Drp1R 4KR using live-
cell imaging and fluorescence recovery after photobleach
(FRAP) analysis in HeLa cells and neurons (Figure 4E;
Supplementary Figure 5D). YFP-Drp1R WT rapidly recycled
between the cytoplasm and mitochondria. YFP-Drp1R 4KR,
however, displayed significantly slower rates of recovery
(t1/2 values) and turnover at mitochondrial loci. Moreover,
there was a greater immobile fraction YFP-Drp1R 4KR com-
pared to YFP-Drp1R WT, indicative of longer residence times
and more stable association of the non-SUMOylatable
Drp1 with mitochondria. Consistent with this, subcellular
fractionation and immunoblotting revealed greater mito-
chondrial association of YFP-Drp1R 4KR compared to YFP-
Drp1R WT (Figure 4F). Taken together, our data show that
SUMOylation regulates Drp1 mitochondrial association.
However, it has also been reported that phosphorylation
of Drp1 at S637 controls its mitochondrial localization
(Chang and Blackstone, 2007). Given the growing number
of examples of interplay between SUMOylation and
phosphorylation (Hietakangas et al, 2006; Wilkinson and
Henley, 2010; Konopacki et al, 2011), we tested if OGD
also regulated Drp1 phosphorylation. However, although
we observed strong phosphorylation following forskolin
application, we did not detect any S637 phosphorylation
under control or OGD conditions in our system (Supplemen-
tary Figure 6A). To further examine any potential cross-talk
between Drp1 SUMOylation and phosphorylation at S637, we
investigated whether SUMOylation of Drp1 is affected by
mutation of S637 to a non-phosphorylatable alanine. Drp1
SUMOylation was not altered by the S637A mutation, further
suggesting that SUMOylation of Drp1 occurs independently of
phosphorylation (Supplementary Figure 6B).
DeSUMOylation of Drp1 increases mitochondrial
fragmentation
Overexpression of SENP3 significantly increases cytochrome
c release but does not release the IMS protein Smac/Diablo, a
marker for MOMP (Figure 3C; Tait and Green, 2011).
Consistent with this, SENP3 overexpression did not lead to
Bax/Bak activation in HeLa cells whereas the protein kinase
inhibitor staurosporine (STS) caused robust activation of
Bax/Bak (Figure 5A). Cytochrome c is also released during
mitochondrial fission, a process driven by Drp1 but not
dependent on MOMP (Youle and van der Bliek, 2012).
To examine whether SENP3 regulates Drp1-dependent
mitochondrial fission, we used MitoTracker to monitor
mitochondrial morphology in cells overexpressing
GFP-SENP3 or inactive GFP-SENP3 C532A. We observed
increased mitochondrial fragmentation in GFP-SENP3
expressing compared to inactive GFP-SENP3 C532A
expressing HeLa cells (Figure 5B), resulting in altered
mitochondrial morphology from predominantly elongated/
tubular to more rounded and fragmented. Similarly, over-
expression of SENP3 in primary cortical neurons had little
effect on the number of mitochondria in dendrite processes
(1.7 mitochondria/10 mm in both GFP-SENP3 and GFP-SENP3
C532A expressing cells), although the mean length of
mitochondria was significantly reduced in cells expressing
WT SENP3 (Figure 5C). This resulted in a decreased dendritic
mitochondrial index (Li et al, 2004), indicative of increased
fission.
In addition, knockdown of endogenous Drp1 and rescue
with non-SUMOylatable GFP-Drp1R 4KR also significantly
increased mitochondrial fission in cultured neurons
(Figure 5D), suggesting that SENP3 regulates mitochondrial
fission through the SUMOylation status of Drp1. Taken
together, these results indicate that SENP3-mediated
deSUMOylation of Drp1 promotes cytochrome c release via
mitochondrial fission.
SENP3 recovery during reoxygenation after OGD
promotes cell death
Most neuronal damage occurs during reperfusion after
ischaemia rather than during the initial insult (Saito et al,
2005). We therefore investigated the effects of OGD or OGD
plus reoxygenation in HEK293 cells and cortical neurons in
Figure 5 SENP3 regulates Drp1-mediated mitochondrial fission. (A) Overexpression of SENP3 does not cause Bax/Bak activation in HeLa cells
whereas staurosporine (STS; 1mM; 2 h) potently activates Bax/Bak. Representative images show immunostaining for active Bax (left panels) or
active Bak (right panels) in GFP-SENP3 or GFP-SENP C532A transfected cells or untransfected staurosporine-treated cells (Green: GFP-SENP3,
Red: active Bax/Bak; Blue: Hoechst; Scale bar: 10mm). (B) Overexpression of SENP3 promotes mitochondrial fission in HeLa cells. Cells
overexpressing GFP-SENP3 or inactive C532A mutant were stained with MitoTracker and mitochondrial morphology classified into one of three
categories: (I) Elongated/Tubular, (II) Intermediate or (III) Fragmented. There was a significantly increased proportion of cells with fragmented
mitochondria in GFP-SENP3 compared to C532A overexpressing cells (Po0.0001, chi square test; n¼ 99 cells for GFP-SENP3 and n¼ 86 cells
for GFP-SENP3 C532A). (C) Representative images showing GFP-SENP3 expressing (upper panels) and GFP-SENP3 C532A expressing neurons
(lower panels) co-transfected with Mito-DsRed (scale: 10 mm, white box ROI magnified below). Data were quantified and expressed as a
dendritic mitochondrial index (total mitochondrial length/dendrite length). Values bar charts are shown as mean±s.e.m. n¼ 29 cells for GFP-
SENP3 and n¼ 27 for C532A, ***Po0.0001). (D) Representative images showing knockdown of endogenous Drp1 and rescue with GFP-Drp1R
WT or non-SUMOylatable Drp1R 4KR in neurons. Non-SUMOylatable Drp1R 4KR increases mitochondrial fission visualized using Mito-DsRed
(scale bar: 10mm, white box ROI magnified below). Mitochondria morphology analysis was performed as in (C). Values in bar charts are shown
as mean±s.e.m. (n¼ 8 cells for GFP-Drp1R WT and n¼ 7 cells for GFP-Drp1R 4KR), *Po0.05.
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which SENP3 was knocked down by RNAi. We monitored
activation of the executioner caspase 3 and measured lactate
dehydrogenase (LDH) release as markers for cell death. No
caspase 3 activation was detected during OGD but marked
cleavage occurred during reoxygenation in HEK293 cells.
SENP3 knockdown greatly attenuated caspase 3 cleavage,
indicating that SENP3 acts upstream caspase 3 activation
(Figure 6A). Similarly, LDH release from HEK293 cells or
cortical neurons was not increased by OGD alone but it was
significantly increased after OGD plus reoxygenation and this
affect was reduced or abolished, respectively, in SENP3
knockdown cells (Figure 6B and C). These effects were
specific to SENP3 since knockdown of SENP1 failed to reduce
LDH release from HEK293 cells after OGD plus reoxygenation
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(Supplementary Figure 7A). These results demonstrate that
preventing the return of SENP3 can protect cells from the
otherwise lethal effects of reoxygenation after OGD.
In a complimentary approach, we enhanced SUMO-2/3
conjugation by overexpression of YFP-SUMO-2 Q90P and
YFP-SUMO-2 DGG in HEK293 cells. SUMO-2 Q90P is resistant
to SENP3-mediated deSUMOylation (Bekes et al, 2011) and
should provide maximal SUMO-2 conjugation whereas
SUMO-2 DGG is unable to conjugate (Li et al, 2006). As
predicted, YFP-SUMO-2 Q90P reduced LDH release compared
to SUMO-2 DGG in cells subjected to OGD plus reoxygenation
(Supplementary Figure 7B) further highlighting the crucial
role of SUMO-2/3 conjugation in cell survival after OGD plus
reoxygenation.
Similar to knocking down SENP3, Drp1 knockdown also
reduced LDH release from HEK293 cells subjected to OGD
plus reoxygenation. Interestingly, there was no additive
protective effect in cells in which both Drp1 and SENP3 were
ablated (Figure 6D), strongly suggesting that the two proteins
act in the same pathway. We then knocked down endogenous
Drp1 in HEK293 cells and rescued with either RNAi-resistant
YFP-Drp1R WT or YFP-Drp1R 4KR (Figure 6E). LDH release
after OGD plus reoxygenation was significantly increased in
cells rescued with Drp1R 4KR compared to Drp1R WT.
Finally, we confirmed that the protective effect of SENP3
knockdown occurs through regulation of Drp1 SUMOylation.
We monitored LDH release after OGD plus reoxygenation
from cells in which both Drp1 and SENP3 were knocked
down and endogenous Drp1 was rescued with either
RNAi-resistant YFP-Drp1R WT or YFP-Drp1R 4KR. Knock-
down of SENP3 reduced LDH release in cells rescued with
YFP-Drp1R WT. However, in cells where endogenous Drp1
was replaced by YFP-Drp1R 4KR, removal of SENP3 did
not reduce the OGD plus reoxygenation induced LDH
release (Figure 6F). Since SENP3 removal failed to protect
cells expressing non-SUMOylatable Drp1 these results
demonstrate that SUMO-2/3-ylation of Drp1 is a critical
step in this previously uncharacterized protective pathway.
Discussion
The UPR is a critical arbiter of cell survival in response to
stress. If the UPR fails to restore proper function then
insurmountable ER stress leads to cell death, but the transi-
tion from pro-survival to pro-apoptotic UPR signalling and
the pathways involved are poorly understood. Protein
SUMOylation is dramatically upregulated by cell stress and
this has been proposed to be a protective cellular response
(Datwyler et al, 2011; Lee et al, 2011; Renner et al, 2011).
However, the mechanisms that regulate SUMOylation and the
key target substrate proteins involved in cytoprotection are
not known. Our results demonstrate that ER stress-induced
degradation of SENP3 modulates protein SUMOylation. This
represents a new aspect of the UPR signalling network in
which enhanced SUMO-2/3-ylation of the GTPase Drp1
provides a pro-survival signal from the UPR to the
mitochondria (Figure 7).
A pivotal finding of this study is that selective degradation
of a SUMO-2/3-specific deSUMOylating enzyme, SENP3, is a
crucial mediator of the cellular response during OGD. SENP3
is selectively degraded during ischaemia leading to increased
total levels of SUMO-2/3 conjugation, which contributes to
cell survival. Levels of SUMO-1 conjugation are not altered.
During reoxygenation after OGD, on the other hand, SENP3
levels are restored with a corresponding decrease in global
SUMO-2/3 conjugation and cells die by apoptosis. Consistent
with this, RNAi-mediated SENP3 knockdown to prevent the
recovery after OGD significantly increases cell survival during
reoxygenation. Importantly, we identify Drp1 as a key SUMO-
2/3 substrate regulated by changes in SENP3 availability.
Knockdown of endogenous Drp1 and rescue with a non-
SUMOylatable mutant abolishes the protective effects of
SENP3 knockdown. Thus, our data demonstrate that en-
hanced degradation and decreased availability of SENP3
during OGD is part of a protective cellular response.
Furthermore, we propose that SENP3 reappearance during
reoxygenation is a major factor in cell death due to reperfu-
sion injury.
Nuclear localized SENP3 is continuously degraded through
the ubiquitin-proteasome pathway under basal conditions.
The rate of proteasomal degradation of SENP3 in the nucleus
can be increased by phosphorylation (Kuo et al, 2008) and
decreased by relatively small increases in reactive oxygen
species (ROS), which can act to enhance SENP3 stability
(Huang et al, 2009). By contrast, our results describe a
distinct pathway activated by extreme cell stress in which
cytoplasmic SENP3 is rapidly degraded by a non-proteasomal
mechanism that does not rely on direct canonical
ubiquitination or phosphorylation. Rather we show that
cathepsin B inhibitor II prevents the OGD-induced loss of
SENP3 in HEK293 cells and that SENP3 is not degraded in
MEFs from cathepsin B knockout mice. In cultured cortical
neurons, however, we were unable to reliably prevent OGD-
induced SENP3 degradation with cathepsin B inhibitor II. The
reasons for this are unclear but we speculate that either the
cathepsin B inhibitor does not work well in primary cultured
neurons, or other lysosomal enzymes compensate for its
inhibition. Nonetheless, taken together our data strongly
suggest that cathepsin B plays a major role in SENP3
degradation.
Our results indicate that regulation of SENP stability is an
important mechanism for controlling cellular SUMOylation.
We show that PERK overexpression or subjecting cells to
OGD for 2 h activates cathepsin B. We attribute the fact that
this cathepsin B activation does not cause significant cell
death to the intensity of the response. We propose that a
likely explanation is that exposure time is the major factor for
cell viability. Prolonged OGD can trigger necroptosis via
lysosome permeabilization whereas shorter OGD triggers
cellular survival mechanisms that may contribute to
the phenomenon of ischaemic pre-conditioning. Further, the
loss of SENP3 during ischaemia and its recovery during
reoxygenation provide an explanation for the widely
observed phenomenon that cells, particularly neurons, can
survive extraordinarily well during the oxygen deprivation
phase of ischaemic insult but undergo massive delayed cell
death following reoxygenation.
SENP3 specifically cleaves SUMO-2/3 from target proteins
and we show that SENP3 knockdown causes a dramatic
increase in total SUMO-2/3-ylation of multiple target pro-
teins. Although changes in global SUMOylation clearly have
far-reaching effects, to investigate the mechanisms under-
lying the cytoprotective actions of SUMO-2/3 it is necessary
to identify specific target proteins. In an attempt to define
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pivotal SUMO substrates we reasoned that proteins involved
in the pathway leading to apoptosis would be likely
candidates.
Drp1 plays a crucial role in mediating cytochrome c release
during apoptosis (Frank et al, 2001; Taguchi et al, 2007;
Ishihara et al, 2009) so how Drp1 is recruited to the
Figure 6 SENP3 regulation of Drp1 SUMOylation plays a critical role in cell death following reoxygenation. (A) SENP3 knockdown decreases
OGD plus reoxygenation-induced caspase 3 cleavage in HEK293 cells. Two days post transfection with Nsi or SENP3i HEK293 cells were
subjected to OGD (2 h) and then reoxygenation (24 h). Lysates were blotted as indicated. (B) SENP3 knockdown decreases LDH release from
HEK293 cells after OGD plus reoxygenation. Cells were treated as in (A) and culture media was sampled after OGD (2 h) and after 24 h
reoxygenation (2 hþ 24 h). (C) SENP3 knockdown decreases LDH release in neurons following OGD plus reoxygenation. Neurons were
infected with retrovirus containing either scrambled shRNA (Scr) or SENP3 shRNA (SENP3 sh), subjected to OGD (2 h) and then reoxygenation
(24 h), and media sampled for LDH as in (B). Inset panels in (B) and (C) show immunoblots of cell lysates confirming SENP3 knockdown. (D)
Knockdown of both SENP3 and Drp1 is not additive on OGD plus reoxygenation-evoked LDH release from HEK293 cells. Immunoblots (right
panel) confirm knockdown of SENP3 and/or Drp1. (E) Drp1 knockdown and rescue with non-SUMOylatable Drp1R 4KR increases LDH release
in response to OGD plus reoxygenation in HEK293 cells (upper panel). Immunoblots (lower panel) confirm knockdown and rescue of Drp1. (F)
SENP3 knockdown does not reduce LDH release induced by OGD plus reoxygenation in Drp1R 4KR-rescued cells. Immunoblots (lower panels)
confirm knockdown of Drp1/SENP3 and rescue of Drp1. In (B–F), values are presented as mean±s.e.m. (nX5 replicates for each group;
*Po0.05; **Po0.01; ***Po0.001). Source data for this figure is available on the online supplementary information page.
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mitochondrial outer membrane is likely to be fundamental in
regulating the cellular response to stress. Phosphorylation of
Ser637 has been reported to regulate the mitochondrial
association of Drp1 (Chang and Blackstone, 2007; Cribbs
and Strack, 2007) but in our system we did not observe any
Drp1 Ser637 phosphorylation in neurons.
In addition, SUMO-1-ylation of Drp1 during apoptotic
cell death has been proposed to enhance stable association
of Drp1 at the mitochondrial membrane (Wasiak et al,
2007), suggesting that SUMO-1-ylation of Drp1 could be
pro-apoptotic. Consistent with this model, overexpression
of SENP5 rescues SUMO-1-induced mitochondrial frag-
mentation whereas silencing of SENP5 caused mitocho-
ndrial fragmentation (Zunino et al, 2007).
Here, we show that Drp1 is a SUMO-2/3 substrate and that
it is an important target for SENP3-mediated deSUMOylation.
In contrast to the apoptotic affects reported for SUMO-1
conjugation, our data using OGD to stress cells strongly
support a cytoprotective role for SUMO-2/3 modification of
Drp1. We demonstrate that SUMO-2/3-ylation modification
acts to partition Drp1 away from mitochondria and that it is
deSUMOylation that enhances mitochondrial localization and
promotes cytochrome c release. It is important to note,
however, that the SENP3 pathway we describe is specific
for SUMO-2/3 and does not impact on SUMO-1. Furthermore,
our OGD protocols, which dramatically reduced SENP3, did
not alter levels of SENP5 protein.
Combining previously reported data with our results it
appears that SUMO-1-ylation of Drp1 enhances mitochon-
drial association and promotes fragmentation and apoptosis
(Harder et al, 2004; Wasiak et al, 2007; Zunino et al, 2007),
whereas Drp1 SUMO-2/3-ylation decreases mitochondrial
localization and reduces apoptosis. Our findings are
consistent with the overall picture that is emerging of SUMO-
ylation, particularly SUMO-2/3-ylation, as an adaptive
protective response to stress. Nonetheless, depending on
the state of the cell, SUMO-1 and SUMO-2/3 conjugation to
Drp1 may exert different effects and exhibit distinct
conjugation dynamics. Although exactly how the balance
between SUMO-1 and/or SUMO-2/3 conjugation to Drp1 is
regulated is not known, our results strongly suggest that the
targeted degradation of a paralogue-specific SENP may
provide a mechanism. Similarly, there is no information on
the interrelationship between conjugation by SUMO-1 and
SUMO-2/3 and further work will be needed to resolve these
issues.
The small proportion of Drp1 that is modified at any given
time argues against a static model in which SUMO-2/3-ylated
Drp1 is cytosolic and deSUMOylated Drp1 associated with the
mitochondrial membrane. Rather, our FRAP data suggest
that SUMO-2/3-ylation can act as a ‘mobilization factor’ in
a dynamic model of constitutive cycling of Drp1 between
the mitochondrial membrane and the cytosol. Thus,
SUMOylation regulates Drp1 residence time at mitochondria
through a balance of Ubc9-mediated SUMO-2/3 modification
and SENP3-mediated deSUMOylation. The downregulation of
SENP3-mediated deSUMOylation during OGD shifts the bal-
ance to decrease the mitochondrial residence time of Drp1,
consequently reducing Drp1-mediated cytochrome c release,
caspase cleavage and apoptosis. Exactly how deSUMOylation
of Drp1 enhances mitochondrial localization is currently
unclear but we speculate that SUMOylation may regulate
the interaction between Drp1 and its putative receptors on
the mitochondrial outer membrane such as Mff, Mid49 and
Mid51 (Youle and van der Bliek, 2012).
We show that SENP3 enhances cytochrome c, but not
Smac/Diablo, release via a mechanism that requires Drp1
activity, but occurs independently of Bax activation and
MOMP. Further, we show that replacement of endogenous
Drp1 with non-SUMOylatable Drp1 4KR enhances mitochon-
drial fragmentation demonstrating that SENP3 activity and
Drp1 SUMOylation regulate mitochondrial fission, which
leads to cytochrome c release. We do not yet have a clear
idea of the mechanism that allows this to be selective for
cytochrome c compared to Smac/Diablo. This will be the
focus of future work but one possibility is that SUMOylation
of Drp1 may regulate its interaction with the mitochondrial
anionic phospholipid cardiolipin (Montessuit et al, 2010).
Since SENP3 levels correlate with cytochrome c release,
and SENP3 recovers during reoxygenation, we reasoned that
removing SENP3 or promoting SUMO-2/3-ylation during
reoxygenation might reduce cell death post-OGD. Consistent
with this, SENP3 knockdown or overexpression of a non-
deconjugatable SUMO-2 afforded significant protection
against cell death during reoxygenation. Enhancing general
Figure 7 Schematic of proposed cell death/survival pathway.
During ischaemic stress, the UPR kinase PERK is activated, which
leads to lysosome-mediated degradation of the SUMO-2/3-specific
deSUMOylating enzyme SENP3. The absence of SENP3 prolongs
Drp1 SUMOylation, favouring localization in the cytosol and redu-
cing Drp1-mediated cytochrome c release. Following reoxygenation,
however, SENP3 levels recover, promoting mitochondrial associa-
tion of Drp1 and cell death.
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levels of SUMOylation has been reported to be protective
after OGD (Lee et al, 2007; Datwyler et al, 2011; Cimarosti
et al, 2012) but here we provide the first example of the
protective effects of SENP3 depletion. Furthermore, the
degree of protection from SENP3 knockdown was greater
than that observed by overexpressing SUMO-2, suggesting
that exploiting the substrate specificity of SENP3-mediated
deSUMOylation could provide a novel therapeutic strategy.
In conclusion, we define a novel cytoprotective pathway in
which SENP3 availability during ischaemia regulates
SUMO-2/3-ylation of Drp1, which, in turn, controls the
dynamics of Drp1 cycling between the mitochondrial outer
membrane and the cytosol. Drp1 SUMOylation promotes
partitioning into the cytosol, which reduces cytochrome c
release and spares the cell from apoptosis. This pathway
represents a novel example of a substrate-specific protective
action of SUMO-2/3-ylation during cell stress and reveals a
potential therapeutic target for increasing resistance to
apoptosis after ischaemia and other insults.
Materials and methods
Plasmids
Constructs were generated using standard cloning procedures and
PCR-based mutagenesis. Details of the plasmids used, their source
and how they were modified are provided in Supplementary data.
Cell culture
Cortical cultures were prepared from E18 Wistar rat embryos by
dissection, trypsin treatment and mechanical dissociation. Cells
were then plated on poly-L-lysine-coated culture dishes at a density
of 3 million per 10 cm dish, 600 K per well for 6-well plates or 25 mm
glass coverslips (250 K per 3.5 mm dish) in Neurobasal medium
(Gibco) containing 10% horse serum, B27 (Gibco), and 5 mM
glutamine and incubated at 371C in humidified air supplemented
with 5% CO2. On the second day, the media was changed for
Neurobasal medium containing B27 and 2 mM glutamine. Cortical
neurons were then fed each week with this serum-free medium
until experimental usage at 14 DIV.
HEK293 and HeLa cells were cultured in Dulbecco’s modified
Eagle’s medium (DMEM; Lonza) containing 10% fetal bovine serum
(FBS), 5 mM glutamine, and 100 units/ml penicillin/streptomycin at
371C in humidified air supplemented with 5% CO2.
MEF cell lines were cultured in DMEM containing 10% FBS,
5 mM glutamine, 100 units/ml penicillin/streptomycin, 0.1 mM non-
essential amino acids (Invitrogen), and 0.05 mM b-mercaptoethanol
(Invitrogen) at 371C in humidified air supplemented with 5% CO2.
PERK / MEFs and their WT controls were a gift from D Ron.
eIF2a S51A MEFs and their WTcontrols were a gift from R Kaufman.
Cathepsin B / primary MEFs and their WT controls were a
gift from C Peters and were cultured in DMEM containing 10%
FBS, 5 mM glutamine, 100 units/ml penicillin/streptomycin.
OGD and reoxygenation
For cortical neurons, OGD was performed within a MACS-VA500
anaerobic workstation (Don Whitley Scientific Limited) supplemen-
ted with 95% N2 and 5% CO2 at 371C for 30–120 min. Details of the
protocols used are provided in Supplementary data.
DNA and siRNA transfections
For DNA transfection into HEK293 cells and HeLa cells, we
used jetPEI reagents (Polyplus Transfection) according to manu-
facturer’s instructions, and cultured cells until use within 48 h.
INTERFERin reagent (Polyplus Transfection) was used for siRNA
transfection and cells were used within 72 h. For DNA and siRNA
co-transfection, we used jetPRIME reagents (Polyplus Transfection)
and used the cells within 72 h. MEFs were transfected with siRNAs
by nucleofector electroporation (program A-23, and MEF solution 2;
Amaxa Biosystems). Primary rat cortical neurons were transfected
using Lipofectamine 2000 reagent (Invitrogen) according to manu-
facturer’s instructions. siRNA duplexes were used as follows: mouse
SENP3 siRNA (ON-TARGET plus SMART pool L-057149-01-005 set
of 4, Thermo Scientific), human SENP3 siRNA (sc-44451, Santa
Cruz) and human Drp1 siRNA (synthesized by Eurofins MWG
Operon).
Retroviral shRNA infection
The shRNA constructs containing gene-specific shRNA expression
vectors in pGFP-V-RS plasmid were purchased from Origene
Technologies, Inc. The following sequence was chosen to silence
SENP3: 50-ACTGGCTCAATGACCAGGTGATGAACATG-30. A construct
of scrambled non-effective shRNA cassette in the same plasmid was
used as negative control. In all, 1mg plasmids were used to transfect
am12 cells, a murine retroviral packaging system (Patience et al,
1998) with Lipofectamine 2000 transfection reagent (Invitrogen).
In all, 46 h post transfection the culture media was collected and
centrifuged at 2000 g for 5 min. Supernatant was aliquoted and kept
at  201C as virus stock. In all, 15–30 ml virus stock was used to
infect B1 million primary cultured cortical neurons at DIV7,
supplemented with a 4mg/ml concentration of Polybrene (hexadi-
methrine bromide) for 6 h. Culture media was then replaced with
fresh media and the cells left until DIV14.
Quantitative RT–PCR
RNA was extracted from 14 DIV primary cortical neuronal cultures
using an RNeasy kit (Qiagen). RNA was DNAse treated and reverse
transcribed (Ambion). SUMO2, SUMO3 and SENP3 mRNAs were
measured using a TaqMan assay-on-demand (Applied Biosystems)
and normalized to 18srRNA (Applied Biosystems) using multiplex-
ing on a SMx3000P system (Stratagene). The probes used were
Rn00821719_g1* for Rat SUMO2, Rn01429214_g1 for Rat SUMO3
and Rn01496196_g1 for Rat SENP3 (Applied Biosystems).
LDH assay
LDH levels in conditioned culture media were assessed using the In
Vitro Toxicology Assay Kit (Lactic Dehydrogenase Based; Sigma).
Briefly, HEK293 cells cultured on 24-well plates or dissociated
cortical neurons cultured on 12-well plates, were subjected to 2 h
OGD or 2 h OGD plus 24 h reoxygenation. In all, 30ml of conditioned
culture medium was taken from each well of the 24-well plates or
12-well plates and spun down to pellet cells or cell debris and 10 ml
of the medium was transferred to each well of a 96-well plate.
LDH assay mixture containing substrate, cofactor and dye solutions
was prepared and 50ml of the mixture was added to each well of the
96-well plate. Following 15 min incubation, the absorbance at
492 nm and at reference 620 nm was measured using a Tecan
program on a plate reader. In some initial experiments using
HEK293 cells, absorbance was measured only at a wavelength of
492 nm. Results shown in each histogram are representative of at
least three experiments carried out using different cell populations.
Subcellular fractionation
Nuclear and non-nuclear fractions from HEK293 cells were prepared
using a Nuclear Extract Kit (Active Motif). Cytosol and mitochon-
dria fractions were prepared using a ProteoExtract Cytosol/
Mitochondria Fractionation Kit (Calbiochem).
In vitro cleavage assay of SENP3 by cathepsin B
Technical difficulties in expressing the catalytic domain of SENP3 in
E. coli have previously been reported previously (Mikolajczyk et al,
2007; Kolli et al, 2010). In agreement with those reports, we were
unable to detect expression of full-length SENP3 in E. coli.
To overcome this, GST-SENP3 or Flag-SENP3 was purified from
HEK293 cells transfected with pEBG-SENP3 or Flag-SENP3 by GST-
pulldown or immunoprecipitation, respectively. In vitro cleavage by
Cathepsin B was performed as previously described (Taha et al,
2005). Briefly, for each reaction, 10ml of GST/GST-SENP3-bound
glutathione-Sepharose 4B beads was added to 7 ml of 3Cathepsin
B reaction buffer containing 150 mM sodium acetate, pH 6.0, 12 mM
EDTA, and 24 mM dithiothreitol, 0.5ml of Cathepsin B (B0.01 units;
ENZO Life Sciences), and 3.5ml of ddH2O. The cleavage reaction
was carried out by incubation at 371C for 30 min. Following
incubation, 5ml 6 SDS loading buffer was added to each sample.
All the samples were subjected to SDS–PAGE and immunoblotting
under denaturing and reducing conditions.
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In vitro kinase assay
In vitro kinase assays were performed as reported previously (Yan
et al, 2002). Briefly, GST or GST-SENP3 was purified from
transfected HEK293 cells by GST-pulldown. HA-PERK, HA-PERK
K618A mutant, or HA-p58IPK was purified from transfected
HEK293 cells by immunoprecipitation. Purified proteins were
mixed in a kinase reaction buffer containing 25 mM HEPES pH
7.4, 25 mM glycerophosphate, 25 mM MgCl2, 2 mM DTT, 0.1 mM
orthovanadate, and 50 M [32P]ATP (10 Ci/mmol), and incubated at
301C for 30 min. The reaction was terminated by adding 10 ml 6
SDS loading buffer. All the samples were subjected to SDS–PAGE
and the gels were stained with Coomasssie blue, destained and
dried before exposure to X-ray autoradiography film.
Preparation of cell lysate, immunoprecipitation and
GST-pulldown
Transfected HEK293 cells were washed once with ice-cold phos-
phate-buffered saline and then lysed in buffer containing 20 mM
Tris, pH 7.4, 137 mM NaCl, 25 mM b-glycerophosphate, 2 mM
sodium pyrophosphate, 2 mM EDTA, 1% Triton X-100, 10%
glycerol, 1 mM phenylmethylsulphonyl fluoride, 1 mM sodium
orthovanadate, 10 mg/ml aprotinin and 10 mg/ml leupeptin.
Following sonication, insoluble material was removed from lysates
by centrifugation for 15 min at 16 000 g. In experiments to detect
cellular levels of SUMOylation, 20 mM N-ethylmaleimide (NEM)
was also added to the lysis buffer. HA or FLAG-tagged proteins
were immunoprecipitated from HEK293 cell lysates using HA
antibody (Roche) or M2 antibody (Sigma). SUMO-2/3 conjugates
were immunoprecipitated from whole cell lysates prepared in the
above-mentioned lysis buffer plus 0.5% SDS using SUMO-2/3 anti-
body (Clone 1E7, MBL). GST-tagged proteins were isolated by
incubating lysates with glutathione-Sepharose 4B (GE Healthcare).
Nickel affinity pulldown
His-SUMO-2 or His-Ub conjugates were purified by Nickel affinity
pulldowns. Briefly, transfected HEK293 cells were immediately
lysed in denaturing buffer containing 6 M guanidinium-HCl, 0.1 M
Na2HPO4/NaH2PO4, 0.01 M Tris–HCl, pH 8.0, and incubated with
Ni2þ—NTA beads (Qiagen) for 2–3 h at room temperature. The
beads were washed twice with the denaturing buffer, two times
with wash buffer containing 8 M urea, 0.1 M Na2PO4/NaH2PO4,
0.01 M Tris–HCl, pH 6.3, and once with PBS. Bound proteins were
eluted in 6 SDS loading buffer and resolved by SDS–PAGE, His-
SUMO-2 or His-Ub conjugates were detected by immunoblotting
using HA or Flag antibody.
Immunoblotting
Samples were resolved by SDS–PAGE (7.5–15% gels) and
transferred onto Immobilon-P membranes (Millipore Inc.), which
were immunoblotted with the antibodies listed in Supplementary
data.
Immunocytochemistry
Cells were fixed for 12 min at RT in 4% paraformladehyde/PBS with
5% sucrose. Following 5 min incubation with 50 mM NH4Cl to
quench residual PFA, cells were permeabilized in 0.1% Triton
X-100/PBS, blocked for 20 min with 10% horse serum/PBS
and then incubated with antibodies. Primary and
secondary antibody incubations were performed in 5% horse
serum/PBS for 1 h at RT, followed by 15 min incubation with
Hoechst 33542 to stain the cell nuclei. Coverslips were mounted
on glass slides in fluoromount medium (Sigma). Immunostaining
was performed using antibodies against SENP3 (D20A10,
Cell Signalling, 1:400), Drp1 (Clone 8, BD Biosciences, 1:100),
cytochrome c (6H2.B4, BD Biosciences, 1:100), active Bax
(Clone 3, BD Biosciences, 1:100), and active Bak (Ab-1/TC-100,
Millipore, 1:100).
Microscopy, image acquisition and analysis
Detailed methods used for the live and fixed cell confocal imaging,
FRAP, mitochondrial morphology and statistical analysis are
provided in Supplementary data.
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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